We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
23 Jan 2021 - 27 Jan 2021
Virtual Venue
24 Feb 2021 - 28 Feb 2021
Virtual Venue

Spot Urine Sample Evaluated for Renal Potassium Loss

By LabMedica International staff writers
Posted on 02 Dec 2020
Print article
Image: The ABL800 FLEX blood gas analyzer measures a full panel of up to 18 STAT parameters on the same blood sample (Photo courtesy of Radiometer).
Image: The ABL800 FLEX blood gas analyzer measures a full panel of up to 18 STAT parameters on the same blood sample (Photo courtesy of Radiometer).
Hypokalemia is characterized by low serum potassium concentrations. Severe hypokalemia can be life threatening, and immediate potassium replacement is often required to prevent sudden cardiac arrest.

Initial identification of hypokalemia etiology is based on an estimate of urine potassium excretion during a 24-hr urine collection in the absence of potassium supplementation, but the utility of this approach in the emergency department is limited.

Endocrinologists at The Affiliated Hospital of Southwest Medical University (Luzhou, China) divided patients with hypokalemia were into two groups: 67 patients with hypokalemia caused by renal potassium loss and 63 patients with hypokalemia caused by extrarenal potassium loss. Arterial blood gases were measured with an ABL800 blood gas analyzer (Radiometer, Copenhagen, Denmark).

Urine potassium concentration (UK), urine creatinine concentration (UCr), urine potassium-creatinine ratio (UK/UCr), fractional excretion of potassium (FEK), transtubular potassium concentration gradient (TTKG), and 24-h urine potassium excretion (24 hUK-calculated) were derived from spot urine samples collected on admission, and were determined using automated methods on a 7170A automatic biochemistry analyzer (Hitachi Healthcare, Tokyo, Japan).

The scientists reported that patients with hypokalemia caused by renal potassium loss had significantly higher UK, UK/UCr, FEK, TTKG and 24 hUK-calculated compared to patients with hypokalemia caused by extrarenal potassium loss. FEK predicted renal potassium loss in hypokalemia with high accuracy at a cut-off of 9.29% (sensitivity, 80.6%; specificity, 85.7%). Patients with primary aldosteronism had significantly higher UK and TTKG compared to patients without primary aldosteronism. There were no significant differences in UK/UCr, FEK or 24 hUK-calculated between patients with primary aldosteronism and not primary aldosteronism. On the spot urine test, FEK showed the highest correlation with 24 hUK-actual during low or high dose potassium chloride infusion.

The authors concluded that prompt treatment with potassium chloride is required for patients with hypokalemia; 24 hUK-actual is not a suitable marker for predicting renal potassium loss in medical practice. Findings from this study suggest that a spot urine sample collected before potassium chloride therapy has utility for differentiating between renal and extrarenal potassium loss in hypokalemia. FEK from a spot urine sample represents a convenient and reliable parameter to predict renal potassium loss in patients with hypokalemia. The study will be published in the December, 2020 issue of the journal Clinica Chimica Acta.

Related Links:
The Affiliated Hospital of Southwest Medical University
Radiometer
Hitachi Healthcare



Print article

Channels

Molecular Diagnostics

view channel
Image: Schematic representation of Chiari malformation type 1; it involves the lower part of the cerebellum known as tonsils, but not the brain stem (Photo courtesy of Healthline).

Common Brain Malformation Traced to Its Genetic Roots

About one in 100 children has a common brain disorder called Chiari 1 malformation, but most of the time such children grow up normally and no one suspects a problem. However about one in 10 of those children,... Read more

Industry

view channel
Image: uPath HER2 Dual ISH image analysis for breast cancer (Photo courtesy of Roche)

Roche Launches Digital Pathology Image Analysis Algorithms for Precision Patient Diagnosis in Breast Cancer

Roche (Basel, Switzerland) has announced the CE-IVD launch of its automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.